Argen X SE ADR (ARGX)

Precedente Chiudi:

$388.20

Aprire:

$389.07

Volume 24 ore:

203.74K

Capitalizzazione di mercato:

$23.40B

Reddito:

$1.23B

Utile/perdita netta:

$-295.05M

Rapporto P/E:

-94.66

EPS:

-4.16

Flusso di cassa netto:

$-910.55M

1 W Prestazione:

+4.93%

1M Prestazione:

+1.74%

6M Prestazione:

-20.13%

1 anno Prestazione:

-2.57%

Intervallo 1D:

$386.42

$397.35

Portata 52W:

$327.73

$550.76

Argen X SE ADR Stock (ARGX) Company Profile

Nome

Argen X SE ADR

Settore

Healthcare (1215)

Industria

Biotechnology (700)

Telefono

31763030488

Indirizzo

Willemstraat 5, Breda

Dipendente

73

Cinguettio

Prossima data di guadagno

2024-05-07

Ultimi documenti SEC

ARGX's Discussions on Twitter

Argen X SE ADR Stock (ARGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-15	Iniziato	Wolfe Research	Peer Perform
2023-12-20	Downgrade	Deutsche Bank	Buy → Hold
2023-12-20	Downgrade	William Blair	Outperform → Mkt Perform
2023-07-31	Iniziato	Scotiabank	Sector Perform
2023-07-24	Downgrade	UBS	Buy → Neutral
2023-07-17	Ripresa	Evercore ISI	Outperform
2023-06-15	Iniziato	Societe Generale	Sell
2023-05-31	Iniziato	UBS	Buy
2023-04-25	Iniziato	Citigroup	Buy
2023-03-14	Aggiornamento	Robert W. Baird	Neutral → Outperform
2022-12-07	Iniziato	William Blair	Outperform
2022-10-12	Iniziato	Oppenheimer	Perform
2022-07-29	Downgrade	Robert W. Baird	Outperform → Neutral
2022-06-28	Ripresa	Stifel	Buy
2022-05-03	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2021-12-08	Iniziato	Wells Fargo	Overweight
2021-11-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-10-29	Aggiornamento	Guggenheim	Neutral → Buy
2021-10-28	Aggiornamento	Raymond James	Outperform → Strong Buy
2021-10-07	Iniziato	Jefferies	Buy
2021-09-23	Aggiornamento	Redburn	Neutral → Buy
2021-09-07	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-07-23	Iniziato	Deutsche Bank	Hold
2021-07-19	Ripresa	Wolfe Research	Outperform
2021-06-18	Iniziato	UBS	Buy
2021-06-04	Ripresa	Robert W. Baird	Outperform
2021-05-10	Aggiornamento	H.C. Wainwright	Neutral → Buy
2021-04-23	Iniziato	Redburn	Neutral
2021-03-05	Reiterato	H.C. Wainwright	Neutral
2021-02-02	Downgrade	Piper Sandler	Overweight → Neutral
2021-01-04	Downgrade	Guggenheim	Buy → Neutral
2020-08-25	Iniziato	Raymond James	Outperform
2020-08-19	Downgrade	Evercore ISI	Outperform → In-line
2020-07-29	Iniziato	H.C. Wainwright	Neutral
2020-02-10	Iniziato	BofA/Merrill	Buy
2019-11-05	Iniziato	Credit Suisse	Neutral
2019-10-31	Aggiornamento	William Blair	Mkt Perform → Outperform
2019-10-22	Iniziato	JP Morgan	Overweight
2019-09-27	Iniziato	Wells Fargo	Market Perform
2019-09-16	Ripresa	Cowen	Outperform
2019-06-28	Iniziato	Robert W. Baird	Outperform
2019-01-18	Ripresa	SunTrust	Buy
2019-01-04	Iniziato	Morgan Stanley	Overweight
2018-12-17	Iniziato	Goldman	Buy
2018-12-14	Iniziato	Wolfe Research	Outperform
2018-06-29	Iniziato	Nomura	Buy
2018-04-09	Iniziato	SunTrust	Buy
2018-01-29	Reiterato	JMP Securities	Mkt Outperform

Mostra tutto

Argen X SE ADR Borsa (ARGX) Ultime notizie

argenx to Present at BofA Securities 2024 Health Care Conference

GlobeNewswire Inc.

Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?

Zacks Investment Research

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

Zacks Investment Research

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect

Zacks Investment Research

argenx to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024

GlobeNewswire Inc.

Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?

Zacks Investment Research

Argen X SE ADR Azioni (ARGX) Dati Finanziari

Argen X SE ADR (ARGX) Reddito 2024

Argen X SE ADR (ARGX) Reddito netto 2024

Argen X SE ADR (ARGX) Flusso di cassa 2024

Argen X SE ADR (ARGX) Utile per azione 2024